Antibody Drug Conjugate Drug Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Adcertis, Kadcyla); Technology (ImmunoGen technology, Seattle Genetics technology, Immunomedics technology); End User (Hospitals, Specialized Cancer Centers, Academic Research Institutes, Biotechnology Companies, Biopharmaceutical Companies, Others) and Geography

Report Code: TIPRE00016840 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Antibody Drug Conjugate Drug is the class of highly potent biopharmaceutical anticancer agents. Antibody drug conjugates have monoclonal antibodies which targets on the specific target site of tumor to destroy cancer cells. Antibody drug conjugates having very potent anti-cancer agents which are linked each other's via a chemical linkage. Antibody drug conjugates have a wide application in oncology and hematology.

MARKET DYNAMICS

The key market drivers for Antibody Drug Conjugate Drug Market Includes, rising prevalence of cancer patients globally especially several grades of lymphomas and solid tumor cancers. Moreover, high R&D investments by biopharmaceutical industries is also expected to boost market growth during the forecast period. Whereas, high cost of the therapy and possible cytotoxity and other side effects due to antibody drug conjugates may have negative impact on market growth during the forecast period.

MARKET SCOPE

The "Antibody Drug Conjugate Drug Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antibody Drug Conjugate Drug market with detailed market segmentation by product, technology and end user. The Antibody Drug Conjugate Drug Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Antibody Drug Conjugate Drug Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Antibody Drug Conjugate Drug Market is segmented on the basis of product, technology and end user. On the basis of product the market is segmented as, Adcertis, Kadcyla. On the basis of technology the market can be segmented as, immunogen technology, seattle genetics technology and immunomedics technology, And on the basis of end user the market is segmented as, hospitals, cancer centers, academic and research institutes, biopharmaceutical companies and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Antibody Drug Conjugate Drug Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antibody Drug Conjugate Drug Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Antibody Drug Conjugate Drug Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antibody Drug Conjugate Drug Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Antibody Drug Conjugate Drug Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Antibody Drug Conjugate Drug Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Antibody Drug Conjugate Drug market in the global market. Below mentioned is the list of few companies engaged in the Antibody Drug Conjugate Drug Market.

The report also includes the profiles of key players in Antibody Drug Conjugate Drug Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Genentech USA,Inc
  •   Seattle Genetics
  •   F. Hoffmann -La Roche Ltd
  •   Takeda Pharmaceuticals
  •   Pfizer, Inc
  •   AbbVie Inc
  •   Immunomedics
  •   ImmunoGen, Inc
  •   Lonza
  •   Creative Biolabs

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibody Drug Conjugate Drug Market - By Product
1.3.2 Antibody Drug Conjugate Drug Market - By Technology
1.3.3 Antibody Drug Conjugate Drug Market - By End User
1.3.4 Antibody Drug Conjugate Drug Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTIBODY DRUG CONJUGATE DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTIBODY DRUG CONJUGATE DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTIBODY DRUG CONJUGATE DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBODY DRUG CONJUGATE DRUG - GLOBAL MARKET OVERVIEW
6.2. ANTIBODY DRUG CONJUGATE DRUG - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTIBODY DRUG CONJUGATE DRUG MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ADCERTIS
7.3.1. Overview
7.3.2. Adcertis Market Forecast and Analysis
7.4. KADCYLA
7.4.1. Overview
7.4.2. Kadcyla Market Forecast and Analysis
8. ANTIBODY DRUG CONJUGATE DRUG MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOGEN TECHNOLOGY
8.3.1. Overview
8.3.2. ImmunoGen technology Market Forecast and Analysis
8.4. SEATTLE GENETICS TECHNOLOGY
8.4.1. Overview
8.4.2. Seattle Genetics technology Market Forecast and Analysis
8.5. IMMUNOMEDICS TECHNOLOGY
8.5.1. Overview
8.5.2. Immunomedics technology Market Forecast and Analysis
9. ANTIBODY DRUG CONJUGATE DRUG MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. SPECIALIZED CANCER CENTERS
9.4.1. Overview
9.4.2. Specialized Cancer Centers Market Forecast and Analysis
9.5. ACADEMIC RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Academic Research Institutes Market Forecast and Analysis
9.6. BIOTECHNOLOGY COMPANIES
9.6.1. Overview
9.6.2. Biotechnology Companies Market Forecast and Analysis
9.7. BIOPHARMACEUTICAL COMPANIES
9.7.1. Overview
9.7.2. Biopharmaceutical Companies Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis

10. ANTIBODY DRUG CONJUGATE DRUG MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antibody Drug Conjugate Drug Market Overview
10.1.2 North America Antibody Drug Conjugate Drug Market Forecasts and Analysis
10.1.3 North America Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Product
10.1.4 North America Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Technology
10.1.5 North America Antibody Drug Conjugate Drug Market Forecasts and Analysis - By End User
10.1.6 North America Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States Antibody Drug Conjugate Drug Market
10.1.6.1.1 United States Antibody Drug Conjugate Drug Market by Product
10.1.6.1.2 United States Antibody Drug Conjugate Drug Market by Technology
10.1.6.1.3 United States Antibody Drug Conjugate Drug Market by End User
10.1.6.2 Canada Antibody Drug Conjugate Drug Market
10.1.6.2.1 Canada Antibody Drug Conjugate Drug Market by Product
10.1.6.2.2 Canada Antibody Drug Conjugate Drug Market by Technology
10.1.6.2.3 Canada Antibody Drug Conjugate Drug Market by End User
10.1.6.3 Mexico Antibody Drug Conjugate Drug Market
10.1.6.3.1 Mexico Antibody Drug Conjugate Drug Market by Product
10.1.6.3.2 Mexico Antibody Drug Conjugate Drug Market by Technology
10.1.6.3.3 Mexico Antibody Drug Conjugate Drug Market by End User
10.2. EUROPE
10.2.1 Europe Antibody Drug Conjugate Drug Market Overview
10.2.2 Europe Antibody Drug Conjugate Drug Market Forecasts and Analysis
10.2.3 Europe Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Product
10.2.4 Europe Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Technology
10.2.5 Europe Antibody Drug Conjugate Drug Market Forecasts and Analysis - By End User
10.2.6 Europe Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antibody Drug Conjugate Drug Market
10.2.6.1.1 Germany Antibody Drug Conjugate Drug Market by Product
10.2.6.1.2 Germany Antibody Drug Conjugate Drug Market by Technology
10.2.6.1.3 Germany Antibody Drug Conjugate Drug Market by End User
10.2.6.2 France Antibody Drug Conjugate Drug Market
10.2.6.2.1 France Antibody Drug Conjugate Drug Market by Product
10.2.6.2.2 France Antibody Drug Conjugate Drug Market by Technology
10.2.6.2.3 France Antibody Drug Conjugate Drug Market by End User
10.2.6.3 Italy Antibody Drug Conjugate Drug Market
10.2.6.3.1 Italy Antibody Drug Conjugate Drug Market by Product
10.2.6.3.2 Italy Antibody Drug Conjugate Drug Market by Technology
10.2.6.3.3 Italy Antibody Drug Conjugate Drug Market by End User
10.2.6.4 Spain Antibody Drug Conjugate Drug Market
10.2.6.4.1 Spain Antibody Drug Conjugate Drug Market by Product
10.2.6.4.2 Spain Antibody Drug Conjugate Drug Market by Technology
10.2.6.4.3 Spain Antibody Drug Conjugate Drug Market by End User
10.2.6.5 United Kingdom Antibody Drug Conjugate Drug Market
10.2.6.5.1 United Kingdom Antibody Drug Conjugate Drug Market by Product
10.2.6.5.2 United Kingdom Antibody Drug Conjugate Drug Market by Technology
10.2.6.5.3 United Kingdom Antibody Drug Conjugate Drug Market by End User
10.2.6.6 Rest of Europe Antibody Drug Conjugate Drug Market
10.2.6.6.1 Rest of Europe Antibody Drug Conjugate Drug Market by Product
10.2.6.6.2 Rest of Europe Antibody Drug Conjugate Drug Market by Technology
10.2.6.6.3 Rest of Europe Antibody Drug Conjugate Drug Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antibody Drug Conjugate Drug Market Overview
10.3.2 Asia-Pacific Antibody Drug Conjugate Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Technology
10.3.5 Asia-Pacific Antibody Drug Conjugate Drug Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antibody Drug Conjugate Drug Market
10.3.6.1.1 Australia Antibody Drug Conjugate Drug Market by Product
10.3.6.1.2 Australia Antibody Drug Conjugate Drug Market by Technology
10.3.6.1.3 Australia Antibody Drug Conjugate Drug Market by End User
10.3.6.2 China Antibody Drug Conjugate Drug Market
10.3.6.2.1 China Antibody Drug Conjugate Drug Market by Product
10.3.6.2.2 China Antibody Drug Conjugate Drug Market by Technology
10.3.6.2.3 China Antibody Drug Conjugate Drug Market by End User
10.3.6.3 India Antibody Drug Conjugate Drug Market
10.3.6.3.1 India Antibody Drug Conjugate Drug Market by Product
10.3.6.3.2 India Antibody Drug Conjugate Drug Market by Technology
10.3.6.3.3 India Antibody Drug Conjugate Drug Market by End User
10.3.6.4 Japan Antibody Drug Conjugate Drug Market
10.3.6.4.1 Japan Antibody Drug Conjugate Drug Market by Product
10.3.6.4.2 Japan Antibody Drug Conjugate Drug Market by Technology
10.3.6.4.3 Japan Antibody Drug Conjugate Drug Market by End User
10.3.6.5 South Korea Antibody Drug Conjugate Drug Market
10.3.6.5.1 South Korea Antibody Drug Conjugate Drug Market by Product
10.3.6.5.2 South Korea Antibody Drug Conjugate Drug Market by Technology
10.3.6.5.3 South Korea Antibody Drug Conjugate Drug Market by End User
10.3.6.6 Rest of Asia-Pacific Antibody Drug Conjugate Drug Market
10.3.6.6.1 Rest of Asia-Pacific Antibody Drug Conjugate Drug Market by Product
10.3.6.6.2 Rest of Asia-Pacific Antibody Drug Conjugate Drug Market by Technology
10.3.6.6.3 Rest of Asia-Pacific Antibody Drug Conjugate Drug Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antibody Drug Conjugate Drug Market Overview
10.4.2 Middle East and Africa Antibody Drug Conjugate Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Technology
10.4.5 Middle East and Africa Antibody Drug Conjugate Drug Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antibody Drug Conjugate Drug Market
10.4.6.1.1 South Africa Antibody Drug Conjugate Drug Market by Product
10.4.6.1.2 South Africa Antibody Drug Conjugate Drug Market by Technology
10.4.6.1.3 South Africa Antibody Drug Conjugate Drug Market by End User
10.4.6.2 Saudi Arabia Antibody Drug Conjugate Drug Market
10.4.6.2.1 Saudi Arabia Antibody Drug Conjugate Drug Market by Product
10.4.6.2.2 Saudi Arabia Antibody Drug Conjugate Drug Market by Technology
10.4.6.2.3 Saudi Arabia Antibody Drug Conjugate Drug Market by End User
10.4.6.3 U.A.E Antibody Drug Conjugate Drug Market
10.4.6.3.1 U.A.E Antibody Drug Conjugate Drug Market by Product
10.4.6.3.2 U.A.E Antibody Drug Conjugate Drug Market by Technology
10.4.6.3.3 U.A.E Antibody Drug Conjugate Drug Market by End User
10.4.6.4 Rest of Middle East and Africa Antibody Drug Conjugate Drug Market
10.4.6.4.1 Rest of Middle East and Africa Antibody Drug Conjugate Drug Market by Product
10.4.6.4.2 Rest of Middle East and Africa Antibody Drug Conjugate Drug Market by Technology
10.4.6.4.3 Rest of Middle East and Africa Antibody Drug Conjugate Drug Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antibody Drug Conjugate Drug Market Overview
10.5.2 South and Central America Antibody Drug Conjugate Drug Market Forecasts and Analysis
10.5.3 South and Central America Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Product
10.5.4 South and Central America Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Technology
10.5.5 South and Central America Antibody Drug Conjugate Drug Market Forecasts and Analysis - By End User
10.5.6 South and Central America Antibody Drug Conjugate Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antibody Drug Conjugate Drug Market
10.5.6.1.1 Brazil Antibody Drug Conjugate Drug Market by Product
10.5.6.1.2 Brazil Antibody Drug Conjugate Drug Market by Technology
10.5.6.1.3 Brazil Antibody Drug Conjugate Drug Market by End User
10.5.6.2 Argentina Antibody Drug Conjugate Drug Market
10.5.6.2.1 Argentina Antibody Drug Conjugate Drug Market by Product
10.5.6.2.2 Argentina Antibody Drug Conjugate Drug Market by Technology
10.5.6.2.3 Argentina Antibody Drug Conjugate Drug Market by End User
10.5.6.3 Rest of South and Central America Antibody Drug Conjugate Drug Market
10.5.6.3.1 Rest of South and Central America Antibody Drug Conjugate Drug Market by Product
10.5.6.3.2 Rest of South and Central America Antibody Drug Conjugate Drug Market by Technology
10.5.6.3.3 Rest of South and Central America Antibody Drug Conjugate Drug Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ANTIBODY DRUG CONJUGATE DRUG MARKET, KEY COMPANY PROFILES
12.1. GENENTECH USA, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SEATTLE GENETICS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TAKEDA PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ABBVIE INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. IMMUNOMEDICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. IMMUNOGEN INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LONZA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CREATIVE BIOLABS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Genentech USA, Inc
2. Seattle Genetics
3. F. Hoffmann-La Roche Ltd
4. Takeda Pharmaceuticals
5. Pfizer Inc
6. AbbVie Inc
7. Immunomedics
8. ImmunoGen Inc
9. Lonza
10. Creative Biolabs
TIPRE00016840
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking